Table 3.
AR is significantly associated with overall survival in melanoma patients.
| Analysis | Patients/Model | HR | 95% CI | p Value * | Variable(s) Included | |
|---|---|---|---|---|---|---|
| Simple variate | Female | 0.49 | 0.28 | 0.86 | 0.012 | AR |
| Male | 0.66 | 0.44 | 0.99 | 0.047 | AR | |
| All | 0.61 | 0.44 | 0.84 | 0.003 | AR | |
| Multivariate | Model 1 | 0.65 | 0.47 | 0.90 | 0.009 | AR, sex, age |
| Model 2 | 0.67 | 0.48 | 0.95 | 0.025 | AR, sex, age, stage (0–4) | |
| Model 3 | 0.68 | 0.48 | 0.96 | 0.029 | AR, sex, age, stage (early, late) | |
| Model 4 | 0.80 | 0.54 | 1.20 | 0.29 | AR, sex, age, stage (early, late), ulceration | |
| Model 5 | 0.59 | 0.40 | 0.87 | 0.008 | AR, sex, age, stage (early, late), Breslow depth (4 category) | |
*, p value: for AR.